Article Text

PDF
Letter
Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis
  1. Jatinder Goyal,
  2. Jodie A Barkin,
  3. Jamie S Barkin
  1. Division of Gastroenterology, University of Miami, Leonard M. Miller School of Medicine, Miami, Florida, USA
  1. Correspondence to Dr Jatinder Goyal, Division of Gastroenterology, University of Miami, Leonard M. Miller School of Medicine, 1400 NW 12th Ave, Miami, FL 33136, USA; jatinder.goyal{at}jhsmiami.org

Statistics from Altmetric.com

We read with great interest the article by Masamune et al1 regarding the role of long-term maintenance corticosteroids in patients with autoimmune pancreatitis (AIP).1 AIP is a steroid responsive disorder, which has two distinct entities with overlapping features, classified as type I and type II AIP. While type I AIP is a part of a spectrum of IgG4-related disease with extrapancreatic manifestations, type II is a pancreas-specific disease. The diagnostic criteria, treatment approach and prognosis are different between the …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.